Discriminative stimulus properties of fenfluramine in an operant task: An analysis of its cue function
- 28 Downloads
- 32 Citations
Abstract
Fenfluramine at a dose of 3.0 mg/kg was found to possess discriminative stimulus properties controlling lever selection by rats in a two-lever operant task. Subjects trained to discriminate the ‘Fenfluramine cue’ failed to generalize to amphetamine in extinction tests at doses between 0.25 and 1.0 mg/kg. Subjects did, however, generalize to the fenfluramine metabolite, norfenfluramine, at a dose of 2.0 mg/kg. These data provide further evidence for a pharmacological difference between fenfluramine and amphetamine, and support the hypothesis that norfenfluramine is an active metabolite of fenfluramine. The relevance of these findings to theoretical and methodological aspects of drug discrimination studies is considered.
Key words
Fenfluramine Norfenfluramine Amphetamine Drug discrimination Stimulus properties of drugs Fixed ratio respondingPreview
Unable to display preview. Download preview PDF.
References
- Barry, H., III: Classification of drugs according to their discriminable effects in rats. Fed. Proc. 33, 1814–1824 (1974)Google Scholar
- Broekkamp, C. L. E., Weemaes, A. J. M., Van Rossum, J. M.: Does fenfluramine act via norfenfluramine?. J. Pharm. Pharmacol. 27, 129–130 (1975)Google Scholar
- Cappell, H., Le Blanc, A. E.: Gustatory avoidance conditioning by drugs of abuse: relationships to general issues in research on drug dependence. In: Food aversion learning (N. W. Milgram, L. Krames, T. M. Alloway, eds.), New York: Plenum Press. (In press) 1976.Google Scholar
- Clineschmidt, B. V., McGuffin, J. C., Pfleuger, A. B., Totaro, J. A.: Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-Hydroxytryptamine-like action?. Neuropharmacol. 14, 301–311 (1975)Google Scholar
- Colpaert, F. C., Lal, H., Niemegeers, C. J. E., Janssen, P. A. J.: Investigations of drug produced and subjectively experienced discriminative stimuli. I. Life Sci. 16, 705–716 (1975a)Google Scholar
- Colpaert, F. C., Niemegeers, C. J. E., Lal, H., Janssen, P. A. J.: Investigations of drug produced and subjectively experienced discriminative stimuli. II. Life Sci. 16, 717–728 (1975b)Google Scholar
- Colpaert, F. C., Niemegeers, C. J. E., Kuyps, J. J. M. D., Janssen, P. A. J.: Apomorphine as a discriminative stimulus and its antagonism by haloperidol. Eur. J. Pharmacol. 32, 383–368 (1975c)Google Scholar
- Colpaert, F. C., Niemegeers, C. J. E., Janssen, P. A. J.: Differential response control by isopropamide: a peripherally controlled discriminative cue. Eur. J. Pharmacol. 34, 381–384 (1975d)Google Scholar
- Duhault, B. J., Malen, Ch., Boulanger, M., Voisin, C., Beregi, L., Schmitt, H.: Fenfluramine and 5-hydroxytryptamine. Arzneim. Forsch. (Drug Res.) 25, 1755–1758 (1975)Google Scholar
- Everitt, B. J., Hackett, N. B.: Central stimulant action of fenfluramine in the rat. Brit. J. Pharmacol. 44, 342–343 (1972)Google Scholar
- Garratini, S., Bizzi, A., De Gaetano, G., Jori, A., Samanin, R.: Recent advances in the pharmacology of anorectic agents. In: Recent advances in obesity research, Vol. 1 (A. Howard, ed.), pp. 354–367. London: Newman 1975Google Scholar
- Gotestam, K. G., Gunne, L. M.: Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects. Brit. J. Addict. 67, 39–44 (1972)Google Scholar
- Goudie, A. J., Taylor, M., Wheeler, T. J.: Chronic anorexic and behavioural effects of the fenfluramine metabolite, norfenfluramine: an evaluation of its role in the actions of fenfluramine. Psychopharmacologia (Berl.) 38, 67–74 (1974)Google Scholar
- Goudie, A. J., Taylor, M.: Time sampling of rat exploratory behaviour: a reliable screening test for the C.N.S. effects of anorexic agents. Psychopharmacologia (Berl.) 35, 1–12 (1974)Google Scholar
- Goudie, A. J., Thornton, E. W.: Effects of drug experience on drug induced conditioned taste aversions: studies with amphetamine and fenfluramine. Psychopharmacologia (Berl.) 44, 77–82 (1975)Google Scholar
- Griffith, J. D., Nutt, J. G., Jasinski, D. R.: A comparison of fenfluramine and amphetamine in man. Clin. Pharmacol. Ther. 18, 563–570 (1975)Google Scholar
- Lyon, M., Robbins, T.: The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Current developments in psychopharmacology, Vol. 2 (W. B. Essman, L. Valzelli, eds.), pp. 79–163. New York: Spectrum Publications Inc. 1975Google Scholar
- Overton, D. A.: State-dependent learning produced by addicting drugs. In: Opiate addiction: origins and treatment (S. Fisher, A. M. Freedman, eds.). New York: John Wiley 1973Google Scholar
- Overton, D. A.: Experimental methods for the study of statedependent learning. Fed. Proc. 33, 1800–1813 (1974)Google Scholar
- Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., Avery, G. S.: Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10, 241–323 (1975)Google Scholar
- Riley, I., Corson, J., Haider, I., Oswald, I.: Fenfluramine overdosage. Lancet 1969 II, 1162Google Scholar
- Stunkard, A. J., Rickels, K., Hesbacher, P.: Fenfluramine in the treatment of obesity. Lancet 1973 I, 503–505Google Scholar
- Taylor, M., Goudie, A. J., Williams, A.: The effects of chronic fenfluramine administration on behavior and body weight. Psychopharmacologia (Berl.) 31, 63–76 (1973)Google Scholar
- Weiskrantz, L.: Memory In: Analysis of behavioural change (L. Weiskrantz, ed.). New York: Harper and Row 1968Google Scholar
- Zolovick, A. J., Stern, W. C., Panksepp, J., Jalowiec, J. E., Morgane, P. J.: Sleep-waking patterns in cats after administration of fenfluramine and other monoaminergic modulating drugs. Pharmacol. Biochem. Behav. 1, 41–46 (1973)Google Scholar